+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Trastuzumab"

Breast Cancer Therapeutics - A Global Market Overview - Product Thumbnail Image

Breast Cancer Therapeutics - A Global Market Overview

  • Report
  • November 2024
  • 257 Pages
  • Global
From
From
HER2 Inhibitors Market Report 2025 - Product Thumbnail Image

HER2 Inhibitors Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Trastuzumab Biosimilars Market Report 2025 - Product Thumbnail Image

Trastuzumab Biosimilars Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
From
Metastatic Breast Cancer Treatment Market Report 2025 - Product Thumbnail Image

Metastatic Breast Cancer Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Herceptin Global Market Report 2025 - Product Thumbnail Image

Herceptin Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
From
From
From
Breast Cancer Drugs Market Report 2025 - Product Thumbnail Image

Breast Cancer Drugs Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Breast Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Breast Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • July 2025
  • 450 Pages
  • Global
From
From
From
HER2 Positive Breast Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

HER2 Positive Breast Cancer- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
Metastatic Breast Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Breast Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 100 Pages
  • Global
From
Loading Indicator

Trastuzumab is a monoclonal antibody used to treat certain types of breast cancer. It is used to treat HER2-positive breast cancer, which is a type of cancer that has a higher than normal amount of a protein called HER2. Trastuzumab works by blocking the HER2 protein, which helps to slow or stop the growth of cancer cells. It is usually given in combination with other chemotherapy drugs. Trastuzumab is typically given intravenously, and can be used in both early and advanced stages of breast cancer. It is also used to reduce the risk of recurrence in patients who have already been treated for HER2-positive breast cancer. Trastuzumab is a widely used drug in the treatment of breast cancer, and is available from a number of pharmaceutical companies. Some of the companies that produce trastuzumab include Roche, Merck, Pfizer, and Amgen. Show Less Read more